Multi-objective Molecular Optimization for Opioid Use Disorder Treatment Using Generative Network Complex.

Area of Science:

• Computational chemistry and pharmacology
• Artificial intelligence in drug discovery

Background:

• Opioid Use Disorder (OUD) presents a critical global health challenge with limited effective therapeutic options.
• There is an urgent requirement for novel medications to treat OUD and related conditions.

Approach:

• A deep generative model integrating stochastic differential equation (SDE)-based diffusion modeling with autoencoder latent spaces was developed.
• The model generates molecules targeting mu, kappa, and delta opioid receptors.
• Generated molecules undergo ADMET property assessment and pharmacokinetic optimization for drug-likeness.

Key Points:

• The study successfully generated a diverse set of drug-like molecules with potential efficacy against multiple opioid receptors.
• Binding affinity predictors were constructed using integrated molecular fingerprints and machine learning algorithms.
• A molecular optimization strategy was employed to enhance pharmacokinetic properties of lead compounds.

Conclusions:

• The developed machine learning platform is a valuable tool for designing and optimizing novel molecules for OUD treatment.
• Further experimental validation is necessary to confirm the pharmacological effects and therapeutic potential of the generated compounds.